Patterns of prescription and usage of triptans in Alsace (France): Misuse is frequent and avoidable;Modes de prescription et de consommation des triptans en Alsace: Un mésusage fréquent mais évitable

Revue Neurologique

Volumn 162, Issue 3, 2006, Pages 347-357

  Perearnau, P ^a   Vuillemet, F ^b   Schick, J ^c   Weill, G ^c  

^a Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^b Pasteur Hospital   (France)

^c Service Médical de l'Assurance Maladie d'Alsace Moselle   (France)

Author keywords

Chronic headache; Drug abuse; Migraine; Prescriptions; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; COCODAMOL; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; IBUPROFEN; KETOPROFEN; NAPROXEN; OPIATE; PARACETAMOL; PIROXICAM; ROFECOXIB; TRAMADOL; TRIPTAN DERIVATIVE;

ANALGESIA; ARTICLE; CHEMOPROPHYLAXIS; COMPUTER; CONTROLLED STUDY; DATA BASE; DRUG CONTRAINDICATION; DRUG MISUSE; FEMALE; FRANCE; HEADACHE; HEALTH INSURANCE; HUMAN; HYPERTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRESCRIPTION; QUESTIONNAIRE; SELF MEDICATION; TENSION HEADACHE;

EID: 33645787519     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75021-4     Document Type: Article

References (21)

1. ANAES. (2003). Recommandations pour la pratique clinique. Prise en charge diagnostique et thérapeutique de la migraine chez l'adulte et chez l'enfant : octobre 2002. Rev Neurol (Paris), 159: 4S3-4S118.
2. ANAES. (2004). Recommandations pour la pratique clinique. CCQ (céphalées chroniques quotidiennes) : diagnostic, rôle de l'abus médicamenteux, prise en charge. Septembre 2004.
3. CNAMTS. (2003). Onze associations médicamenteuses formellement contre-indiquées. Situation en 2000. Paris, CNAMTS, janvier 2003.
4. DODICK DW, MARTIN VT, SMITH T, SILBERSTEIN S. (2004). Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache, 44 (Suppl 1): S20-S30.
5. ETMINAN M, TAKKOUCHE B, CAAMAÑO ISORNA F, SAMII A. (2005). Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ, 330: 63.
6. FERRARI MD, ROON IK, LIPTON RB et al. (2001). Oral triptans (serotonins 5-HT 1b/1d agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet, 358: 1668-1675.
7. FREDIANI F, CANNATA AP, MAGNONI A, PECCARISI C, BUSSONE G. 2003). The patient with medication overuse: clinical management problems. Neurol Sci, 24 (Suppl 2): S108-S111.
8. LANTÉRI-MINET M, AURAY JP, EL HASNAOUI A et al. (2003). Prevalence and description of chronic daily headache in the general population in France. Pain, 102:143-149.
9. LIMMROTH V, KAZARAWA Z, FRITSCHE G et al. (1999). Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet, 353: 378.
10. LIMMROTH V, KAZARAWA Z, FRITSCHE G, PRZYWARA S, DIENER HC. (2002). Features of medication overuse headache following overuse of different acute headache drugs. Neurology, 59: 1011-1014.
11. LIPTON RB, BIGAL ME, GOADSBY PJ. (2004). Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia, 24: 321-332.
12. LUCAS C, AURAY JP, GAUDIN AF et al. (2004). Use and misuse of triptans in France: data from the GRIM 2000 population survey. Cephalalgia, 24: 197-205.
13. LUCAS C, CHAFFAUT C, ARTAZ MA et al. (2005). FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalagia, 25: 267-279.
14. MAC GREGOR EA, BRANDES J, EIKERMANN A. (2003). Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache, 43: 19-26.
15. PRADALIER A, AURAY JP, EL HASNAOUI A et al. (2004). Economic impact of migraine and other episodic headaches in France; data from the GRIM2000 study. Pharmacoeconomics, 22: 985-999.
16. SILBERSTEIN SD, LIU D. (2002). Drug overuse and rebound headache. Curr Pain Headache Rep, 6: 240-247.
17. TAIMI C, NAVEZ M, PERRIN AM, LAURENT B. (2001). Céphalées induites par abus des traitements symptomatiques antalgiques et antimigraineux. Rev Neurol (Paris), 157: 1221-1234.
18. TEPPER SJ, RAPOPORT AM, SHEFTELL FD. (2002). Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol, 59: 1084-1088.
19. TEPPER S, ALLEN C, SANDERS D, GREENE A, BOCCUZZI S. (2003). Coprescription of triptans with potentially interacting medications: a cohort study involving 240268 patients. Headache, 43: 44-48.
20. TILLY B, SALANAVE B, RICORDEAU P et al. (2004). Hypertension artérielle sévère en France : traitement et contrôle tensionnel en 1999 et 2003. Rev Med Ass Maladie, 35: 167-180.
21. ZWARTH JA, DYB G, HAGEN K et al. (2003). Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology, 61: 160-164.